[1]史红杰,张兴伟,马二梅,等.逐瘀消癥方治疗子宫肌瘤疗效及对患者细胞凋亡蛋白和雌、孕激素受体表达的影响*[J].陕西中医,2020,(11):1559-1562.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.011]
　SHI Hongjie,ZHANG Xingwei,MA Ermei,et al.Curative effect of Zhuyu Xiaozheng decoction on uterine fibroids and its effect on apoptotic protein and estrogen and progesterone receptor[J].,2020,(11):1559-1562.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.011]
点击复制

逐瘀消癥方治疗子宫肌瘤疗效及对患者细胞凋亡蛋白和雌、孕激素受体表达的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年11期
页码:
1559-1562
栏目:
临床研究
出版日期:
2020-11-05

文章信息/Info

Title:
Curative effect of Zhuyu Xiaozheng decoction on uterine fibroids and its effect on apoptotic protein and estrogen and progesterone receptor
作者:
史红杰; 张兴伟; 马二梅; 张宝亚; 张海燕; 史惠博; 马会妙
河北省保定市第四中心医院(保定 072350)
Author(s):
SHI Hongjie; ZHANG Xingwei; MA Ermei; et al.
The Fourth Central Hospital of Baoding City(Baoding 072350)
关键词:
子宫肌瘤;  逐瘀消癥方;  细胞凋亡蛋白;  雌激素受体;  孕激素受体;  子宫动脉搏动指数
Keywords:
Uterine fibroids;  Zhuyu Xiaozheng decoction;  Apoptotic protein;  Estrogen receptor;  Progesterone receptor;  Pulsation index
分类号:
R737.33
DOI:
DOI:10.3969/j.issn.1000-7369.2020.11.011
文献标志码:
A
摘要:
目的:探讨逐瘀消癥方治疗子宫肌瘤的疗效及对患者细胞凋亡蛋白和雌、孕激素受体的影响。方法:将98例子宫肌瘤患者按照随机数字表法分为两组各49例,对照组予以米非司酮片口服治疗,治疗组在对照组用药基础上应用逐瘀消癥方,疗程均为12周。比较两组治疗前后子宫体积、肌瘤大小、子宫动脉血流动力学指标; 并比较两组血清性激素、细胞凋亡蛋白和雌、孕激素受体水平与两组临床疗效。结果:治疗组治疗后子宫和瘤体均小于对照组(P<0.05); 子宫动脉搏动指数(PI)、阻力指数(RI)高于对照组(P<0.05),收缩期峰值流速(PSV)低于对照组(P<0.05); 血清黄体生成素(LH)、卵泡生成素(FSH)、雌二醇(E2)、孕酮(P)、Bcl-2、雌激素受体(ER)、孕激素受体(PR)水平均低于对照组(P<0.05),Bax水平高于对照组(P<0.05),临床疗效优于对照组(P<0.05),差异均有统计学意义。结论:逐瘀消癥方可降低性激素水平,改善子宫血流动力指标,有助于缩小肌瘤体积和子宫体积,其机制可能与调节细胞凋亡蛋白和雌、孕激素受体有关。
Abstract:
Objective:To investigate the curative effect of Zhuyu Xiaozheng decoction on uterine fibroids and its effect on apoptotic protein and estrogen and progesterone receptor.Methods:98 patients with uterine fibroids were divided into two groups according to the random number table method,each group of 49 cases,the control group was treated orally with Mifepristone tablets,the treatment group was treated with Zhuyu Xiaozheng decoction on the basis of the treatment of the control group,the course of treatment was 12 weeks.Uterine volume,fibroid size and indicators of uterine arterial hemodynamics before and after treatment were compared between the two groups.Levels of serum sex hormones,apoptotic proteins and estrogen and progesterone receptors were compared between the two groups.The clinical efficacy of the two groups was also compared.Results:After treatment,the uterus and tumor in the treatment group were smaller than that in the control group(P<0.05).The pulse index(PI)and resistance index(RI)of uterine artery were higher than those of the control group(P<0.05),and the peak systolic velocity(PSV)was lower than the control group(P<0.05).The levels of serum LH,FSH,estradiol(E2),progesterone(P),Bcl-2,estrogen receptor(ER)and progesterone receptor(PR)were all lower than that of the control group(P<0.05),while the levels of Bax were higher than that of the control group(P<0.05),and the clinical efficacy was better than that of the control group(P<0.05),with statistically significant differences.Conclusion:Zhuyu Xiaozheng decoction can reduce the level of sex hormone,improve the uterine hemodynamic index,and help reduce the volume of fibroids and uterus.The mechanism may be related to the regulation of apoptotic protein and estrogen and progesterone receptor.

参考文献/References:

[1] Masciocchi C,Arrigoni F,Ferrari F,et al.Uterine fibroid therapy using interventional radiology mini-invasive treatments:Current perspective[J].Med Oncol,2017,34(4):52-64.
[2] Giarre GL,Franchini ML,Castellacci E,et al.Ulipristal acetate in symptomatic uterine fibroids.a real-world experience in a multicentric Italian study[J].Gynecol Endocrinol,2020,36(2):171-174.
[3] 沈 萍,董丽君,沈小珩.川芎化瘤合剂治疗气滞血瘀型子宫肌瘤的临床观察[J].上海中医药杂志,2020,54(2):70-73.
[4] 魏巧芳.不同剂量米非司酮对子宫内膜异位症疗效对比研究[J].药品评价,2019,16(20):28-29.
[5] 索南草,陈剑虹.桂茯化癥汤治疗微小子宫肌瘤临床研究[J].陕西中医,2019,40(8):1063-1065,1084.
[6] 孙运明,周珊娜,唐禹馨.桂枝茯苓方治疗子宫肌瘤的疗效及对基质金属蛋白酶2、核因子-κB p65表达水平的影响[J].中华中医药学刊,2019,37(5):1212-1214.
[7] 谢 幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:205-206.
[8] 张玉玲.中医妇科学[M].7版.北京:中国中医药出版社,2002:308-313.
[9] Mcwilliams MM,Chennathukuzhi VM.Recent advances in uterine fibroid etiology[J].Semin in Reprod Med,2017,35(2):181-189.
[10] 田 艺,张 坤,苏 青,等.腹腔镜下子宫肌瘤微创剔除术治疗子宫肌瘤临床疗效及对患者应激反应的影响研究[J].陕西医学杂志,2018,47(1):93-95.
[11] Marciniak A,Szydkowska I,Brodowska A,et al.Newmethods of uterine fibroids treatment[J].Pol Merkur Lekarski,2016,41(246):303-305.
[12] 张 欣,朱 琰,宋知理,等.大黄虫丸联合米非司酮治疗治疗子宫肌瘤的临床研究[J].现代药物与临床,2019,34(9):2704-2708.
[13] 王瑞婷,须义珍,梁阿娟,等.子宫肌瘤发病的相关因素和中医证型研究[J].吉林中医药,2017,37(6):571-574.
[14] 莫 琼,郝二伟,覃文慧,等.平性活血化瘀中药物质基础与药理作用的研究进展[J].中国实验方剂学杂志,2020,26(1):205-216.
[15] 李文静,李雪岩,崔 涛,等.莪术-三棱药对合煎液对大鼠子宫肌瘤的防治作用及机制研究[J].中国药房,2017,28(19):2609-2612.
[16] 蔡尚霞,姜海英,杨 浩.子宫肌瘤患者血清VEGF、HIF-1ɑ和TGF-ɑ水平变化的临床意义[J].中国实验诊断学,2019,23(11):1951-1952.
[17] 王随郧,庹明玉.Bcl-2高表达、Bax及Beclin1表达缺失与子宫肌瘤发生的关系[J].解放军预防医学杂志,2018,36(7):951-952.
[18] 邓欢庆,田新玲.妊娠期子宫肌瘤组织及正常子宫平滑肌组织中的ER、PR表达情况分析[J].中国妇幼保健,2019,34(3):672-674.
[19] Sarais V,Cermisoni GC,Schimberni M,et al.Human chorionic gonadotrophin asa possible mediator of leiomyoma growth during pregnancy:molecular mechanisms [J].Int J Mol Sci,2017,18(9):2014.

相似文献/References:

[1]陈静鸽,梁 艳,周 斌.消癥汤对子宫肌瘤剔除术患者术后恢复的影响研究*[J].陕西中医,2019,(5):620.
[2]索南草,陈剑虹△.桂茯化癥汤治疗微小子宫肌瘤临床研究[J].陕西中医,2019,(8):1063.
　SUO Nancao,CHEN Jianhong..Suppression of Guifu Huazheng decoction in the treatment of micro uterine fibroids[J].,2019,(11):1063.
[3]张 瑾,杨 帆,郑雪绒,等.活血消癥汤配合针灸及子宫动脉介入栓塞术治疗子宫肌瘤临床研究[J].陕西中医,2022,(11):1617.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.030]

备注/Memo

备注/Memo:
*河北省保定市科技局课题(18ZF256)
更新日期/Last Update: 2020-11-09